5 research outputs found

    Cyclospora cayetanensis in Two Immunocompetent Patients in Istanbul

    No full text
    Cyclospora cayetanensis is a frequently reported microorganism which causes diarrhea in both immunocompromised and immunocompetent patients. Despite new information on this emerging pathogen, significant gaps remain in our knowledge. There is a need to accurately diagnose and get information because the coccidian parasites are nearly never diagnosed, even upon the clinician’s request. Two immunocompetent patients with Cyclospora cayetanensis infections were presented and literatur was reviewed in this manuscript

    In vitro activities of colistin, tigecycline and tobramycin, alone or in combination, against carbapenem-resistant enterobacteriaceae strains

    No full text
    WOS: 000366948100009PubMed ID: 27842873The aim of this study was to investigate the activities of various antibiotics, alone or in combination, against carbapenem-resistant Enterobacteriaceae (CRE). Minimum inhibitory concentrations (MICs) of meropenem, colistin, tigecycline and tobramycin were determined by microbroth dilution against 40 clinical strains. Carbapenemase-encoding genes were detected by PCR using specific primers. The in vitro synergistic activities of tigecycline, colistin and tobramycin in double antibiotic combinations were determined by the microbroth chequerboard technique, and results were interpreted using the fractional inhibitory concentration index (FICI). To confirm the results acquired by the chequerboard method, time-kill assays were performed on eight isolates representing four different susceptibility patterns. Based on MIC90 values, colistin was the most potent agent, followed by tigecycline and tobramycin. According to PCR studies, carbapenem resistance in tested Enterobacteriaceae isolates was most often mediated by OXA-48-type carbapenemases. With an FICI of <= 0.5 as the cut-off, synergistic interactions were most frequent with tigecycline + tobramycin (30%); other results for synergistic interactions were 23% for colistin + tobramycin and 9% for colistin + tigecycline. By time-kill assays, all tested antibiotic combinations demonstrated synergistic activity against at least three of the eight strains at 1x or 4x MIC. Overall, the combinations used in this study were effective regimens, demonstrating synergy or no interaction (indifference) against all tested strains. No antagonism was observed with either of the techniques. The findings of this study might play a useful role in selecting appropriate combinations when a single agent is inadequate against CRE strains.Research Fund of The University of Istanbul (Istanbul, Turkey) [4703]This work was supported by a grant from the Research Fund of The University of Istanbul (Istanbul, Turkey) [Project no. 4703]
    corecore